BNTC Benitec Biopharma Inc.

NASDAQ
$9.04

Benitec Biopharma Inc. (BNTC) is confirmed to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.31 per share.

Benitec Biopharma Beat Consensus Estimates
Friday, November 13, 2026 · 8:00 AM ET
Earnings Date
2nd Quarter, Dec 2026
Nov 13
Friday · Before Open
Earnings Whisper
-
vs ($0.31)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Benitec Biopharma Inc.

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.